We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Partnerships Using Optical Imaging to Fight Cancer

By MedImaging staff writers
Posted on 04 Apr 2007
Experts believe the hospitals could save money and reduce waiting times if optical coherence tomography (OCT) imaging was used instead of taking a biopsy. More...


As a result, two leading UK hospitals have teamed up with Michelson Diagnostics, Ltd. (MDL; Kent) in the fight against cancer. Gloucestershire Royal Hospital and University College London Hospital (UCLH) are both eager to evaluate MDL's latest medical imaging system for research into rapid in-vivo identification of cancers affecting the cervix, esophagus, skin, lung, and other organs.

The new Michelson Diagnostics scanner employs optical coherence tomography (OCT) to visualize tissue structure in real time below the surface of a scanned organ. OCT makes this possible at far higher resolution than is possible with ultrasound or magnetic resonance imaging (MRI) scans.

At Gloucestershire Royal Hospital, Dr. Nick Stone, consultant clinical scientist in biophotonics research, will use the scanner to look at cervical and esophageal tumor tissue. "My team want to assess how useful OCT imaging could be in helping clinicians to diagnose, monitor, and target the treatment of cancer,” said Dr Stone. "The next step will be to repeat the tests in-vivo. We believe the NHS [National Health Service] could reduce costs and waiting times with the clinical implementation of OCT, both for biopsy targeting and real-time diagnostics.”

Dr. Colin Hopper, head of maxillofacial surgery at UCLH, is eager to obtain in-vivo images of basal-cell skin carcinomas with the Michelson Diagnostics system. "We are very excited about the breakthrough in image quality that this system offers,” Dr. Hopper said. "OCT could revolutionize the surveillance of pre-cancers in the mouth by eliminating waiting for biopsy results and by minimizing surgery for cancer through improved disease mapping, all while maximizing cure rates.”

The research programs are due to start in late March 2007. They will last at least four months and will compare OCT scans taken with the Michelson Diagnostics equipment with histology from the same tissue samples from a sizeable range of patients.


Related Links:
Michelson Diagnostics

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Ultrasound System
FUTUS LE
Exam Table
PF400
Portable Jaundice Management Device
Nymphaea
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.